The Limb Salvage Center

Filter Your Results

 

News

 

FDA Clears Ra Medical's Dabra Atherectomy System to Treat PAD

May 30, 2017 -- Ra Medical Systems, Inc. announced that the US Food and Drug Administration has granted market clearance for the company’s Dabra (Destruction of Arterios…

CMS Approves Coverage for Supervised Exercise Therapy for PAD Patients

May 30, 2017 -- The Centers for Medicare & Medicaid Services (CMS) has determined that the evidence is sufficient to cover supervised exercise therapy (SET) for beneficiar…

FDA Approves Phase 1 Trial of Alucent Medical's Natural Vascular Scaffold Therapy

May 16, 2017 -- Alucent Medical, Inc. announced that it has received US Food and Drug Administration (FDA) approval to begin phase 1 human clinical studies of the company'…

QT Vascular and Medtronic Enter Into Asset Purchase Option Agreement for the Chocolate PTA Catheter

May 12, 2017 -- QT Vascular Ltd. announced that it has entered into an asset purchase option agreement with Medtronic for the acquisition of QT Vascular's non -- drug-coat…

DANCE Trial Investigates Dexamethasone Infusion to Enhance Femoropopliteal Revascularization

May 11, 2017 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced that Ehrin J. Armstrong, MD, presented results from an analysis of inflammat…

Ask the Experts: How Can Current Endpoints in Below-the-Knee Clinical Trials Be Improved?

With Thomas Zeller, MD; Mahmood K. Razavi, MD, FSIR, FSVM; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Marianne Brodmann, MD

May 2017—Experts discuss how to better align trial endpoints for improved assessment of below-the-knee outcomes in patients with critical limb ischemia.

Ultrasound Techniques to Enhance Our Understanding of Below-the-Knee Outcomes

Francesco Liistro, MD

May 2017—Tips for using extravascular ultrasound guidance to evaluate below-the-knee disease and select the proper tools for treatment.

Cone-Beam CT and Advanced Perfusion in CLI Interventions

Andrew Holden, MBChB, FRANZCR, EBIR

May 2017—Objectively measuring tissue perfusion at the site of tissue loss using two- and three-dimensional techniques.

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.